Canterbury DHB
Investigations for less intensive treatments need to be discussed with the Consultant.
|
Test required |
Volume of blood/container |
---|---|---|
Lymph node biopsy |
Consider pathology review. |
|
History and physical examination |
History to document “B” symptoms and any symptoms suggestive of possible sites of involvement. Examination to detect lymphadenopathy, enlargement of liver or spleen, skin involvement, tumour masses, CNS involvement. |
|
Blood tests |
CBCD, blood film, reticulocytes, ESR. |
3 x 5 mL EDTA mauve top, 1 x 5 mL plain. |
|
ONCO profile, Ca++, PO4, urate, AST, GGT and LDH, SPE, immunoglobulin levels, thyroid function test, beta-2 microglobulin, CRP |
1 x 5 mL heparin, 1 x 5 mL plain. |
|
Virology serology, HbSAg, HCV, herpes simplex/zoster, CMV. HIV - test requires patient permission. |
1 x 5 mL plain request long term storage. |
|
HLA typing if allografting is a possibility. |
Contact SCT Coordinator. 4 x 10 mL CPDA (yellow top), 1 x 10 mL plain, 1 x 5 mL EDTA |
Bone marrow |
Bone marrow aspirate and trephine, immunophenotyping. Discuss with Consultant the need for cell markers, cytogenetics and DNA analysis. |
Arrange with laboratory registrar. |
Radiology |
CXR, CT of neck, chest, abdomen and pelvis. Consider CT sinuses |
|
CSF |
Perform if neurological symptoms or signs or high risk of CNS involvement Cell count, microscopy ± flow cytometry |
Sample to Cell Markers lab |
Microbiology |
Swabs from nostrils, throat, perineum and groin labelled “for Staph aureus carriage” (and MRSA if appropriate). Swab any infected lesion ± sputum. Blood cultures if febrile. |
Send to Microbiology. |
Other |
ECG, MSU, ECHO. |
|
Referrals |
|
|
A lymph node biopsy specimen is also appropriate for cytogenetics studies. Bone marrow may be uninformative - there is often a low proportion of lymphoma cells in marrow and they are often reluctant to grow in culture.
Topic Code: 5948